ZLAB — ZAI LAB LTD

Ownership history in Frazier Life Sciences Management, L.P.  ·  4 quarters on record

This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in ZAI LAB LTD (ZLAB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.83% (2025 Q2)
Avg. % of fund
1.24%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 1,902,320 +275,000 +16.9% 0.90% $33.6M $17.64
2025 Q3 ADDED 1,627,320 +319,182 +24.4% 1.65% $55.1M $33.89
2025 Q2 ADDED 1,308,138 +958,138 +273.8% 1.83% $45.7M $34.97
2025 Q1 INITIATED 350,000 — — 0.58% $12.6M $36.14
% of Fund (quarterly)    ZLAB price (monthly, adj. close)

Other funds also holding ZLAB

As of 2025 Q4 — sorted by position size

B Group, Inc. 5.21% XY Capital Ltd 3Y 2.25% SUPERSTRING CAPITAL MANAGEMENT LP 1.86% ADAR1 Capital Management, LLC 1.59% RTW INVESTMENTS, LP 3Y 7Y 1.23% Rock Springs Capital Management LP 3Y 7Y 0.73% DCF Advisers, LLC 3Y 0.46% Privium Fund Management B.V. 3Y 0.43% NAN FUNG TRINITY (HK) Ltd 3Y 0.38% Virtus Investment Advisers, LLC 3Y 7Y 0.18%
← Back to Frazier Life Sciences Management, L.P. Holdings